ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Lynparza, Bevacizumab Trial Meets Primary Endpoint for Advanced Ovarian Cancer
August 19, 2019AstraZeneca and Merck announced positive results from the Phase III PAOLA-1 trial in women with advanced ovarian cancer. The trial, in the 1st-line maintenance setting ... -
NICE fail to recommend AstraZeneca's cancer drug Olaparib on cost effectiveness basis
November 12, 2018Britain’s cost effectiveness body the National Institute of Health and Care Excellence (NICE) has chosen not to recommend AstraZeneca’s Olaparib for women
Pharma Sources Insight January 2025
